SOFA-2 Score in Turkish ICUs
Recruiting
Observational Study
Intensive Care Unit Patients
Critically Ill Intensive Care Unit Patients
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,200 (estimated)
- Sponsor
- Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate how well a new scoring system called the Sequential Organ Failure Assessment-2 (SOFA-2) works in adult intensive care units in Türkiye.
SOFA-2 is designed to measure the severity of organ dysfunction in critically ill patients using routinely collected clinical and laboratory data. It is an updated version of the original SOFA score and reflects modern intensive care p…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older
* Admission to a participating intensive care unit in Türkiye
* Intensive care unit stay longer than 24 hours
Exclusion Criteria:
* Patients younger than 18 years
* Pregnant patients
* Organ donors
* Patients with unknown intensive care unit dis…
Contacts